|
OLA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.023800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.25820000000687E-05 |
| Normal-vs-Stage2 |
8.184000E-02 |
| Normal-vs-Stage3 |
1.115230E-01 |
| Normal-vs-Stage4 |
1.555610E-01 |
| Stage1-vs-Stage2 |
6.959600E-01 |
| Stage1-vs-Stage3 |
2.022600E-01 |
| Stage1-vs-Stage4 |
5.508600E-01 |
| Stage2-vs-Stage3 |
6.035800E-01 |
| Stage2-vs-Stage4 |
8.497800E-01 |
| Stage3-vs-Stage4 |
7.836800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58740000000468E-05 |
| Normal-vs-AfricanAmerican |
2.591600E-01 |
| Normal-vs-Asian |
8.182800E-01 |
| Caucasian-vs-AfricanAmerican |
9.57209999999931E-05 |
| Caucasian-vs-Asian |
1.043030E-01 |
| AfricanAmerican-vs-Asian |
7.488000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.040100E-03 |
| Normal-vs-Female |
3.198300E-04 |
| Male-vs-Female |
2.947600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.551830E-01 |
| Normal-vs-Age(41-60Yrs) |
2.199400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.943300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.310200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.215200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.980800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.955200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.161800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.312800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.930400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.972400E-01 |
| Normal-vs-Grade 2 |
4.28119999995591E-06 |
| Normal-vs-Grade 3 |
1.695830E-02 |
| Normal-vs-Grade 4 |
4.572800E-01 |
| Grade 1-vs-Grade 2 |
1.720480E-02 |
| Grade 1-vs-Grade 3 |
4.381400E-01 |
| Grade 1-vs-Grade 4 |
9.016800E-01 |
| Grade 2-vs-Grade 3 |
2.880100E-02 |
| Grade 2-vs-Grade 4 |
1.385160E-01 |
| Grade 3-vs-Grade 4 |
7.187200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.03660002593165E-10 |
| Normal-vs-ccB subtype |
3.624200E-01 |
| ccA subtype-vs-ccB subtype |
3.85969999999736E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.061360E-03 |
| Normal-vs-N1 |
5.968600E-01 |
| N0-vs-N1 |
5.991200E-01 |
|
|
